Fangmei An

1.3k total citations
43 papers, 952 citations indexed

About

Fangmei An is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Fangmei An has authored 43 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 21 papers in Cancer Research and 14 papers in Surgery. Recurrent topics in Fangmei An's work include MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (9 papers). Fangmei An is often cited by papers focused on MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (9 papers). Fangmei An collaborates with scholars based in China, United States and Australia. Fangmei An's co-authors include Qiang Zhan, Min Xia, Florin M. Selaru, Qiang Zhan, Esteban Mezey, Sumitaka Yamanaka, Qinglin Zhang, Yang Jiao, Qing Xie and Junli Ding and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Fangmei An

40 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangmei An China 18 601 573 241 147 112 43 952
Dequan Wu China 15 463 0.8× 356 0.6× 234 1.0× 187 1.3× 70 0.6× 33 869
Jingjing Zeng China 15 395 0.7× 243 0.4× 131 0.5× 96 0.7× 139 1.2× 52 675
Jirong Huo China 19 566 0.9× 296 0.5× 310 1.3× 147 1.0× 228 2.0× 56 1.0k
Xuequan Yao China 20 494 0.8× 305 0.5× 149 0.6× 313 2.1× 172 1.5× 37 921
Qi Song China 19 523 0.9× 377 0.7× 101 0.4× 321 2.2× 209 1.9× 50 1.0k
Liang Ji China 15 550 0.9× 235 0.4× 204 0.8× 183 1.2× 52 0.5× 26 865
Yifeng Tian China 16 479 0.8× 413 0.7× 104 0.4× 203 1.4× 102 0.9× 37 775
Wen Ni China 12 884 1.5× 730 1.3× 78 0.3× 154 1.0× 83 0.7× 18 1.2k
Hiroki Shimizu Japan 17 364 0.6× 187 0.3× 279 1.2× 254 1.7× 196 1.8× 92 857
Jin He China 16 570 0.9× 356 0.6× 90 0.4× 167 1.1× 98 0.9× 47 907

Countries citing papers authored by Fangmei An

Since Specialization
Citations

This map shows the geographic impact of Fangmei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangmei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangmei An more than expected).

Fields of papers citing papers by Fangmei An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangmei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangmei An. The network helps show where Fangmei An may publish in the future.

Co-authorship network of co-authors of Fangmei An

This figure shows the co-authorship network connecting the top 25 collaborators of Fangmei An. A scholar is included among the top collaborators of Fangmei An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangmei An. Fangmei An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Deyuan, Chuanli Ren, Yuanliang Gu, et al.. (2025). Heterogeneity of T cells regulates tumor immunity mediated by Helicobacter pylori infection in gastric cancer. BMC Cancer. 25(1). 567–567.
2.
Shen, Yao, Xiaojuan Gao, Xiaoxue Zhang, et al.. (2025). Endoscopists and endoscopic assistants’ qualifications, but not their biopsy rates, improve gastric precancerous lesions detection rate. World Journal of Gastrointestinal Endoscopy. 17(4). 104097–104097.
4.
An, Fangmei, Yan Ge, Wei Ye, et al.. (2024). Machine learning identifies a 5-serum cytokine panel for the early detection of chronic atrophy gastritis patients. Cancer Biomarkers. 41(1). 25–40. 1 indexed citations
5.
Shen, Xiao, Qunyan Zhou, Qiang Zhan, et al.. (2021). Dietary xylo‐oligosaccharide ameliorates colonic mucus microbiota penetration with restored autophagy in interleukin‐10 gene–deficient mice. Journal of Parenteral and Enteral Nutrition. 46(5). 1130–1140. 6 indexed citations
6.
An, Fangmei, Liang-Yun Zhou, Yuqing Wu, et al.. (2021). Carcinoembryonic Antigen Related Cell Adhesion Molecule 6 Promotes Carcinogenesis of Gastric Cancer and Anti-CEACAM6 Fluorescent Probe Can Diagnose the Precancerous Lesions. Frontiers in Oncology. 11. 643669–643669. 8 indexed citations
7.
Mei, Jie, et al.. (2020). Systematic Characterization of the Expression and Prognostic Values of Formin-Like Gene Family in Gastric Cancer. DNA and Cell Biology. 39(9). 1664–1677. 10 indexed citations
8.
Ji, Lin, Bin Zhou, Ying Cai, et al.. (2019). Community-Based Pilot Study of a Screening Program for Gastric Cancer in a Chinese Population. Cancer Prevention Research. 13(1). 73–82. 17 indexed citations
9.
Zhang, Yunan, et al.. (2019). Up-regulation of miR-155 contributes to TNF-mediated hepatocyte apoptosis in acute liver failure. The Turkish Journal of Gastroenterology. 30(5). 475–484. 7 indexed citations
10.
Luo, Judong, Changsong Zhang, Qiang Zhan, et al.. (2018). Profiling circRNA and miRNA of radiation-induced esophageal injury in a rat model. Scientific Reports. 8(1). 14605–14605. 21 indexed citations
11.
Nie, Jihua, Jingying Zhang, Lili Wang, et al.. (2017). Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4. Journal of Experimental & Clinical Cancer Research. 36(1). 183–183. 35 indexed citations
12.
Xia, Min, Fang Wu, Qiang Zhan, et al.. (2016). Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma. Tumor Biology. 37(11). 15019–15029. 33 indexed citations
13.
Zhang, Ting, et al.. (2015). Sodium Butyrate Reduces Organ Injuries in Mice with Severe Acute Pancreatitis Through Inhibiting HMGB1 Expression. Digestive Diseases and Sciences. 60(7). 1991–1999. 36 indexed citations
14.
An, Fangmei, Qiang Zhan, Min Xia, et al.. (2014). From Moderately Severe to Severe Hypertriglyceridemia Induced Acute Pancreatitis: Circulating MiRNAs Play Role as Potential Biomarkers. PLoS ONE. 9(11). e111058–e111058. 38 indexed citations
15.
Yamanaka, Sumitaka, Alexandru Olaru, Fangmei An, et al.. (2012). MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. Digestive and Liver Disease. 44(7). 589–596. 57 indexed citations
16.
Yamanaka, Sumitaka, Nathaniel R. Campbell, Fangmei An, et al.. (2012). Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma. Cell Cycle. 11(14). 2729–2738. 78 indexed citations
17.
Zhao, Gangde, Baoyan An, Huijuan Zhou, et al.. (2012). Impairment of the retinoic acid-inducible gene-I-IFN-β signaling pathway in chronic hepatitis B virus infection. International Journal of Molecular Medicine. 30(6). 1498–1504. 9 indexed citations
18.
An, Fangmei, Guijun Zhao, Lingnan Lin, et al.. (2012). miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. APOPTOSIS. 17(7). 702–716. 75 indexed citations
19.
An, Fangmei, Sumitaka Yamanaka, Sarah E. Allen, et al.. (2012). Silencing of miR-370 in Human Cholangiocarcinoma by Allelic Loss and Interleukin-6 Induced Maternal to Paternal Epigenotype Switch. PLoS ONE. 7(10). e45606–e45606. 42 indexed citations
20.
Olaru, Alexandru, Gabriel Ghiaur, Sumitaka Yamanaka, et al.. (2010). MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. Hepatology. 54(6). 2089–2098. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026